Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A healthcare team at a leading consulting firm wanted to better understand how anti-cancer pharmaceuticals are evaluated for inclusion on payer formularies. They were conducting strategy research on behalf of a pharmaceutical company. They needed a large…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A due diligence team at a leading consulting firm needed to quickly get up to speed on data center storage solutions. To better understand the major players and potential market size for these solutions, they were looking…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A team at a leading management consulting firm was working on a tight timeline to better understand trends in Pharmacy Benefit Managers (PBMs). They were conducting competitive analysis within marketing divisions evaluation to identify potential savings. They…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A consulting team was just staffed on a PE due diligence project and needed to answer the question: “At what rate is business shifting to the cloud?”   GUIDEPOINT SOLUTION Guidepoint quickly vetted over 200 industry experts,…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  Client Situation   A consulting team’s private equity due diligence engagement required them to quickly get up to speed on the molded rigid plastic packaging market. – Specifically the competitive landscape, differentiation, and pricing.   Guidepoint Solution Guidepoint quickly vetted…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A consulting director working at a Beijing-based tech advisory firm needed to get up to speed quickly on the taxi-hailing app market in Southeast Asia. His client, a firm considering an investment in the sector, wanted to…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION In biotechnology, developing a new cutting-edge treatment that will help millions of Americans, and doing it faster than anyone else, is what you’re supposed to do. But being a thought leader in the field is who you…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A successful company will have a comprehensive knowledge of its products. They’ll know what it does, who uses it, and why. But what happens when a potential new use comes along that might open up an entirely…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION When Nevro, a manufacturer and distributor of a medical device to relieve back pain, announced an IPO, hedge funds sat up straight and took notice. Physicians in Europe and Australia had started to implant Nevro’s Senza HF10…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A private equity (PE) firm specializing in the healthcare sector was evaluating investing in a company developing a device with the potential to treat glaucoma patients. While the device has a highly specialized use, the analysts at…

Read More